FDA clears ZYN nicotine pouches as lower-risk alternative to cigarettes
TL;DR
The FDA authorized 20 ZYN nicotine pouch products (in 3 mg and 6 mg strengths) to be marketed as lower risk than cigarettes, though not as a quit-smoking aid. The approval requires five years of post-market studies on risk perception and youth uptake, with the possibility of reversal if youth use rises. Experts warn nicotine addiction remains a concern and that many users may not fully switch from smoking, even as some flavors appeal to younger people.
- Some ZYN nicotine pouches can be sold as safer than cigarettes, FDA says NBC News
- FDA allows Philip Morris to market Zyn as less harmful than cigarettes CNN
- FDA allows ZYN pouches to market relative health benefits Axios
- FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes CNBC
- FDA allows Zyn pouches to be marketed as less harmful than cigarettes The Hill
Want the full story? Read the original reporting
Read on NBC News